stockrowGlobus Medical, Inc. (GMED) vs 10x Genomics (TXG)
- Globus Medical, Inc. GMED 72.24 −11.30%
- 10x Genomics TXG 58.35 +0.50%
Globus Medical, Inc. and 10x Genomics are both Medical Devices companies. Globus Medical, Inc. is the larger, with a market value of $10.9B against $7.6B — 1.4× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Globus Medical, Inc. trades at 19.5×. Globus Medical, Inc. grew revenue faster over the last twelve months: 13.4% against −4.28%. Globus Medical, Inc. has the higher net margin (17.8% vs −12.2%) and the higher return on invested capital (8.86% vs −20.2%). Across the 19 metrics below, Globus Medical, Inc. leads on 17 and 10x Genomics on 2.
Valuation
Profitability
| Metric | GMED | TXG | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.12% | 70.03% | 57.76% |
| Operating margin | 21.65% | (14.33%) | (15.07%) |
| Net margin | 17.76% | (12.18%) | (14.45%) |
| Free cash flow margin | 24.42% | 19.68% | (3.88%) |
| Return on equity | 12.13% | (9.40%) | (10.35%) |
| Return on assets | 10.50% | (7.47%) | (17.26%) |
| Return on invested capital | 8.86% | (20.20%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack